Meramec Financial Planners’s Bio-Techne TECH Stock Holding History

Meramec Financial Planners’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-136	Closed	-$8.24K	–	614
2026 Q1	$8.24K	Hold	136	–	–	﹤0.01%	337
2025 Q4	$9.08K	Buy	+136	New	+$8.26K	﹤0.01%	331

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Meramec Financial Planners's TECH Position: Q2 2026 in Review

Meramec Financial Planners sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 136 shares — an estimated $8.24K sold.

Meramec Financial Planners first reported a position in TECH in Q4 2025 and held it in 2 quarters. The position peaked at $9.08K in Q4 2025. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Meramec Financial Planners reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
Meramec Financial Planners sold 136 Bio-Techne shares in Q2 2026, an estimated $8.24K.
Meramec Financial Planners first reported a position in Bio-Techne in Q4 2025 and held it in 2 quarters.
Meramec Financial Planners's Bio-Techne position peaked at $9.08K in Q4 2025.
593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Meramec Financial Planners's 13F filing for Q2 2026, filed 29 Jul 2026.